(19)
(11) EP 3 585 816 A1

(12)

(43) Date of publication:
01.01.2020 Bulletin 2020/01

(21) Application number: 18758109.5

(22) Date of filing: 27.02.2018
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61P 29/00(2006.01)
A61K 39/395(2006.01)
A61P 35/00(2006.01)
(86) International application number:
PCT/IB2018/000253
(87) International publication number:
WO 2018/154391 (30.08.2018 Gazette 2018/35)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD TN

(30) Priority: 27.02.2017 AU 2017900656

(71) Applicant: Monash University
Clayton, Victoria 3800 (AU)

(72) Inventors:
  • MACKAY, Charles, Reay
    Clayton 3800 (AU)
  • ROBERT, Remy, Michel
    Clayton 3800 (AU)

(74) Representative: HGF Limited 
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) CXCR2 ANTIBODIES AND USES THEREOF